ConvaTec Group Plc
OTC: CNVVF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Jonathan Peter Mason
- Employees
- 10,489
- Headquarters
- Reading, United Kingdom
- IPO year
- 2017
- Market cap
- $5.3B
- Website
- https://www.convatecgroup.com
Loading CNVVF…
Loading profile data…Frequently asked questions about CNVVF
What does ConvaTec Group Plc (CNVVF) do?
ConvaTec Group Plc is a global medical technology company focused on creating, producing, and distributing a wide array of healthcare products. Their offerings span several key areas: Advanced Wound Management: This includes specialized dressings and skincare solutions for treating both acute and chronic wounds, which can arise from conditions l...
Where does CNVVF trade?
ConvaTec Group Plc (CNVVF) trades on the Other OTC.
What sector is CNVVF in?
ConvaTec Group Plc (CNVVF) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of ConvaTec Group Plc?
Jonathan Peter Mason is the chief executive officer of ConvaTec Group Plc (CNVVF).
Where is ConvaTec Group Plc headquartered?
ConvaTec Group Plc is headquartered in United Kingdom.
Does CNVVF pay a dividend?
Yes — ConvaTec Group Plc (CNVVF) paid a trailing twelve-month dividend of USD 0.07 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CNVVF go public?
ConvaTec Group Plc (CNVVF) completed its initial public offering in 2017.